Amarin Sinks After Vascepa Patent Trial Judges Are Revealed

Shares of Amarin moved lower after the judges were posted for the company's Federal Circuit appeal of the Vascepa patent invalidation versus generics.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.